Control Bionics Limited (ASX:CBL)
Australia · Delayed Price · Currency is AUD 0.0700
+0.0040 (6.06%)
Nov 26, 2025, 4:10 PM AEST
Control Bionics Market Cap
Control Bionics has a market cap or net worth of 24.75 million as of November 26, 2025. Its market cap has increased by 57.65% in one year.
Market Cap
24.75M
Enterprise Value
24.51M
Revenue
6.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since December 7, 2020, Control Bionics's market cap has decreased from 98.33M to 24.75M, a decrease of -74.83%. That is a compound annual growth rate of -24.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 23.33M | 54.32% |
| Dec 31, 2024 | 15.12M | 126.88% |
| Dec 29, 2023 | 6.66M | -55.36% |
| Dec 30, 2022 | 14.93M | -59.58% |
| Dec 30, 2021 | 36.94M | -52.85% |
| Dec 31, 2020 | 78.33M | -20.34% |
| Dec 7, 2020 | 98.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 86.37B |
| Pro Medicus | 26.26B |
| Cochlear | 17.46B |
| Sonic Healthcare | 11.41B |
| Ramsay Health Care | 7.19B |
| Ansell | 5.13B |
| Telix Pharmaceuticals | 4.66B |
| Mesoblast | 2.96B |